Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.11.23
/
50%
€22.40
Target price
20.11.24
€32.94
Performance (%)
134.38%
Price
05.06.24
€52.50
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. has seen massive gains of 134.38%. This prediction currently runs until 20.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 12.179% | 12.179% |
| iShares Core DAX® | 0.597% | 3.083% |
| iShares Nasdaq 100 | 0.899% | 5.338% |
| iShares Nikkei 225® | 1.775% | -1.206% |
| iShares S&P 500 | 0.990% | 3.500% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $36.00 price target on the stock.
Ratings data for INSM provided by MarketBeat